Article Detail - JE Part B
Billing and Coding: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test - R2
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: October 01, 2020
Summary of Article Changes: Revisions are due to the annual ICD-10 updates and become effective on 10/1/2020
Added to ICD-10 Codes that Support Medical Necessity Group I:
J84.170: Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere
J84.178: Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere
Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the "Covered Tests" or the "Excluded Tests" webpage.
To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Thu, 10 Sep 2020 17:59:52 +0000